Moving towards individualized medicine with pharmacogenomicsEVANS, William E; RELLING, Mary V.Nature (London). 2004, Vol 429, Num 6990, pp 464-468, issn 0028-0836, 5 p.Article

Acute lymphoblastic leukemiaPUI, Ching-Hon; RELLING, Mary V; DOWNING, James R et al.The New England journal of medicine. 2004, Vol 350, Num 15, pp 1535-1548, issn 0028-4793, 14 p.Article

Role of pharmacogenomics and pharmacodynamics in the treatment of acute lymphoblastic leukaemiaPUI, Ching-Hon; RELLING, Mary V; EVANS, William E et al.Baillière's best practice & research. Clinical haematology. 2002, Vol 15, Num 4, pp 741-756, issn 1521-6926, 16 p.Article

Methotrexate intracellular disposition in acute lymphoblastic leukemia: A mathematical model of γ-glutamyl hydrolase activity¹PANETTA, John Carl; WALL, Amelia; PUI, Ching-Hon et al.Clinical cancer research. 2002, Vol 8, Num 7, pp 2423-2429, issn 1078-0432Article

Higher activity of polymorphic NAD(P)H : quinone oxidoreductase in liver cytosols from blacks compared to whitesGONZALEZ COVARRUBIAS, Vanessa; LAKHMAN, Sukhwinder S; FORREST, Alan et al.Toxicology letters. 2006, Vol 164, Num 3, pp 249-258, issn 0378-4274, 10 p.Article

Pediatric acute lymphoblastic leukemia: where are we going and how do we get there?PUI, Ching-Hon; MULLIGHAN, Charles G; EVANS, William E et al.Blood. 2012, Vol 120, Num 6, pp 1165-1174, issn 0006-4971, 10 p.Article

A semiparametric Bayesian model for repeatedly repeated binary outcomesQUINTANA, Fernando A; MÜLLER, Peter; ROSNER, Gary L et al.Applied statistics. 2008, Vol 57, Num 4, pp 419-431, issn 0035-9254, 13 p.Article

Pharmacogenetics of Human Carbonyl Reductase 1 (CBR1) in Livers from Black and White DonorsGONZALEZ-COVARRUBIAS, Vanessa; JIANPING ZHANG; KALABUS, James L et al.Drug metabolism and disposition. 2009, Vol 37, Num 2, pp 400-407, issn 0090-9556, 8 p.Article

Nonadherence to Oral Mercaptopurine and Risk of Relapse in Hispanic and Non-Hispanic White Children With Acute Lymphoblastic Leukemia: A Report From the Children's Oncology GroupBHATIA, Smita; LANDIER, Wendy; MASCARENHAS, Leo et al.Journal of clinical oncology. 2012, Vol 30, Num 17, pp 2094-2101, issn 0732-183X, 8 p.Article

Pharmacokinetic, pharmacodynamic, and pharmacogenetic determinants of osteonecrosis in children with acute lymphoblastic leukemiaKAWEDIA, Jitesh D; KASTE, Sue C; RELLING, Mary V et al.Blood. 2011, Vol 117, Num 8, pp 2340-2347, issn 0006-4971, 8 p.Article

Germline genomic variants associated with childhood acute lymphoblastic leukemiaTREVINO, Lisa R; WENJIAN YANG; PUI, Ching-Hon et al.Nature genetics. 2009, Vol 41, Num 9, pp 1001-1005, issn 1061-4036, 5 p.Article

APAI-1 (SERPINE1) polymorphism predicts osteonecrosis in children with acute lymphoblastic leukemia : a report from the Children's Oncology GroupFRENCH, Deborah; HAMILTON, Leo H; MATTANO, Leonard A et al.Blood. 2008, Vol 111, Num 9, pp 4496-4499, issn 0006-4971, 4 p.Article

Genetic Polymorphisms in the Carbonyl Reductase 3 Gene CBR3 and the NAD(P)H:Quinone Oxidoreductase 1 Gene NQ01 in Patients Who Developed Anthracycline-related Congestive Heart Failure After Childhood CancerBLANCO, Javier G; LEISENRING, Wendy M; GONZALEZ-COVARRUBIAS, Vanessa M et al.Cancer. 2008, Vol 112, Num 12, pp 2789-2795, issn 0008-543X, 7 p.Article

Pharmacogenetics of minimal residual disease response in children with B-precursor acute lymphoblastic leukemia : a report from the Children's Oncology GroupDAVIES, Stella M; BOROWITZ, Michael J; DAS, Soma et al.Blood. 2008, Vol 111, Num 6, pp 2984-2990, issn 0006-4971, 7 p.Article

Cumulative incidence of secondary neoplasms as a first event after childhood acute lymphoblastic leukemiaHIJIYA, Nobuko; HUDSON, Melissa M; RIVERA, Gaston K et al.JAMA, the journal of the American Medical Association. 2007, Vol 297, Num 11, pp 1207-1215, issn 0098-7484, 9 p.Article

Karyotypic abnormalities create discordance of germline genotype and cancer cell phenotypesQING CHENG; WENJIAN YANG; RAIMONDI, Susana C et al.Nature genetics. 2005, Vol 37, Num 8, pp 878-882, issn 1061-4036, 5 p.Article

Acute lymphoblastic leukemia with TEL-AML1 fusion has lower expression of genes involved in purine metabolism and lower de novo purine synthesisZAZA, Gianluigi; WENJIAN YANG; KAGER, Leo et al.Blood. 2004, Vol 104, Num 5, pp 1435-1441, issn 0006-4971, 7 p.Article

Results of therapy for acute lymphoblastic leukemia in black and white childrenPUI, Ching-Hon; SANDLUND, John T; RAIMONDI, Susana C et al.JAMA, the journal of the American Medical Association. 2003, Vol 290, Num 15, pp 2001-2007, issn 0098-7484, 7 p.Article

Effect of Allopurinol Versus Urate Oxidase on Methotrexate Pharmacokinetics in Children With Newly Diagnosed Acute Lymphoblastic LeukemiaCREWS, Kristine R; YINMEI ZHOU; PAULEY, Jennifer L et al.Cancer. 2010, Vol 116, Num 1, pp 227-232, issn 0008-543X, 6 p.Article

Genetic predictors of glucocorticoid-induced hypertension in children with acute lymphoblastic leukemiaKAMDEM, Landry K; HAMILTON, Leo; CHENG CHENG et al.Pharmacogenetics and genomics (Print). 2008, Vol 18, Num 6, pp 507-514, issn 1744-6872, 8 p.Article

A substrate specific functional polymorphism of human γ-glutamyl hydrolase alters catalytic activity and methotrexate polyglutamate accumulation in acute lymphoblastic leukaemia cellsQING CHENG; WU, Bainan; KAGER, Leo et al.Pharmacogenetics (London). 2004, Vol 14, Num 8, pp 557-567, issn 0960-314X, 11 p.Article

HPLC determination of thiopurine nucleosides and nucleotides in vivo in lymphoblasts following mercaptopurine therapyDERVIEUX, Thierry; YAQIN CHU; YI SU et al.Clinical chemistry (Baltimore, Md.). 2002, Vol 48, Num 1, pp 61-68, issn 0009-9147Article

Prognostic Impact of Absolute Lymphocyte Counts at the End of Remission Induction in Childhood Acute Lymphoblastic LeukemiaRUBNITZ, Jeffrey E; CAMPBELL, Patrick; CAMPANA, Dario et al.Cancer. 2013, Vol 119, Num 11, pp 2061-2066, issn 0008-543X, 6 p.Article

Dexamethasone exposure and asparaginase antibodies affect relapse risk in acute lymphoblastic leukemiaKAWEDIA, Jitesh D; CHENGCHENG LIU; PUI, Ching-Hon et al.Blood. 2012, Vol 119, Num 7, pp 1658-1664, issn 0006-4971, 7 p.Article

PACSIN2 polymorphism influences TPMT activity and mercaptopurine-related gastrointestinal toxicitySTOCCO, Gabriele; WENJIAN YANG; CHENG CHENG et al.Human molecular genetics (Print). 2012, Vol 21, Num 21, pp 4793-4804, issn 0964-6906, 12 p.Article